MOLECULAR GENETICS, DIAGNOSIS AND TREATMENT OF BREAST CANCER: REVIEW ARTICLE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NOORI DALOII M.R.; TABARESTANI S.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Sabzevar University of Medical Sciences Year:2010 | Volume:17 | Issue:2 (56) Page(s): 74-87

Download Full-Text

Persian Verion

View:

9,015

Download:

Cites:

Information Journal Paper

Title

MOLECULAR GENETICS, DIAGNOSIS AND TREATMENT OF BREAST CANCER: REVIEW ARTICLE

Author(s)

NOORI DALOII M.R. | TABARESTANI S. | Issue Writer Certificate

Keywords

CANCERQ2

BREASTQ3

MOLECULAR GENETICSQ3

DIAGNOSISQ3

TREATMENTQ3

Abstract

Breast CANCER is the most common CANCER among women, and one out of 8 or 10 women is diagnosed with BREAST CANCER. This type of CANCER is an extremely heterogenous disease, which is classified into multiple categories including LCIS (Lobular carcinoma in situ), DCIS (Ductal carcinoma in situ), and invasive carcinoma. BRCA1 and BRCA2 are two major high-risk genes associated with hereditary BREAST CANCER. Mutations in CHEK2 gene also contribute to a substantial fraction of familial BREAST CANCER. Susceptibility alleles in other genes are also rare causes of BREAST CANCER. More than 1000 mutations have been identified in BRCA1 and BRCA2, and molecular assays for detecting mutations in these genes are now well established. Mutations in BRCA1 and BRCA2 cause genomic instability, which leads to alterations in additional key genes including tumor suppressor genes and/or oncogenes.There is a promise of tailoring TREATMENT programs for individual women in near future. The emergence of miRNAs as regulators of gene expression identifies them as a novel candidate for diagnostic and prognostic indicators and therapeutic targets. The ability of miRNAs to simultaneously regulates many target genes and makes them attractive candidates for regulating stem cell self-renewal and cell fate decisions. The involvement of miRNAs in the initiation and progression of human malignancy holds much potential for new developments in current diagnostic and therapeutic strategies in the management of patients with BREAST CANCER. The identification of novel miRNAs, the elucidation of their mRNA targets, and an understanding of their functional effects will improve our knowledge of the roles of these novel biomarkers in carcinogenesis, including BREAST CANCER, and open avenues for potential therapeutic intervention.

Cites

References

Cite

APA: Copy

NOORI DALOII, M.R., & TABARESTANI, S.. (2010). MOLECULAR GENETICS, DIAGNOSIS AND TREATMENT OF BREAST CANCER: REVIEW ARTICLE. JOURNAL OF SABZEVAR UNIVERSITY OF MEDICAL SCIENCES, 17(2 (56)), 74-87. SID. https://sid.ir/paper/82358/en

Vancouver: Copy

NOORI DALOII M.R., TABARESTANI S.. MOLECULAR GENETICS, DIAGNOSIS AND TREATMENT OF BREAST CANCER: REVIEW ARTICLE. JOURNAL OF SABZEVAR UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2010;17(2 (56)):74-87. Available from: https://sid.ir/paper/82358/en

IEEE: Copy

M.R. NOORI DALOII, and S. TABARESTANI, “MOLECULAR GENETICS, DIAGNOSIS AND TREATMENT OF BREAST CANCER: REVIEW ARTICLE,” JOURNAL OF SABZEVAR UNIVERSITY OF MEDICAL SCIENCES, vol. 17, no. 2 (56), pp. 74–87, 2010, [Online]. Available: https://sid.ir/paper/82358/en

Related Journal Papers